The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


0.5 milligram(s) Coated tablet

Pfizer Europe MA EEIGEU/1/01/171/14

Main Information

Trade NameRapamune
Active SubstancesSirolimus
Strength0.5 milligram(s)
Dosage FormCoated tablet
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/01/171/14

Group Information

ATC CodeL04AA Selective immunosuppressants
L04AA10 sirolimus


Licence Issued24/01/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back